{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:50:44Z","timestamp":1792824644852,"version":"4.5.0"},"reference-count":43,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/501100000098","name":"Stem Cell Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000101","name":"Pierre Elliott Trudeau Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,1,9]]},"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify the frequency and qualitative characteristics of stem cell-related marketing claims made on websites of clinics featuring common types of complementary and alternative medicine practitioners. The involvement of complementary and alternative medicine practitioners in the marketing of stem cell therapies and stem cell-related interventions is understudied. This research explores the extent to which they are involved and collaborate with medical professionals. This knowledge will help with identifying and evaluating potential policy responses to this growing market.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic website analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Global. US and English-language bias due to methodology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Representations made on clinic websites in relation to practitioner types, stem cell therapies and their targets, stem cell-related interventions. Statements about stem cell therapies relating to evidence of inefficacy, limited evidence of efficacy, general procedural risks, risks specific to the mode of therapy, regulatory status, experimental or unproven nature of therapy. Use of hype language (eg, language that exaggerates potential benefits).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>243 websites offered stem cell therapies. Many websites advertised stem cell transplantation from multiple sources, such as adipose-derived (112), bone marrow-derived (100), blood-derived (28), umbilical cord-derived (26) and others. Plant stem cell-based treatments and products (20) were also advertised. Purposes for and targets of treatment included pain, physical injury, a wide range of diseases and illnesses, cosmetic concerns, non-cosmetic ageing, sexual enhancement and others. Medical doctors (130), chiropractors (53) and naturopaths (44) commonly work in the clinics we found to be offering stem cell therapies. Few clinic websites advertising stem cell therapies included important additional information, including statements about evidence of inefficacy (present on only 12.76% of websites), statements about limited evidence of efficacy (18.93%), statements of general risks (24.69%), statements of risks specific to the mode(s) of therapy (5.76%), statements as to the regulatory status of the therapies (30.86%) and statements that the therapy is experimental or unproven (33.33%). Hype language was noted (31.69%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Stem cell therapies and related interventions are marketed for a wide breadth of conditions and are being offered by complementary and alternative practitioners, often in conjunction with medical doctors. Consumer protection and truth-in-advertising regulation could play important roles in addressing misleading marketing practices in this area.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-019414","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T08:15:37Z","timestamp":1519805737000},"page":"e019414","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":53,"title":["Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites\u2019 marketing of stem cell therapies"],"prefix":"10.1136","volume":"8","author":[{"given":"Blake","family":"Murdoch","sequence":"first","affiliation":[{"name":"Faculty of Law, Health Law Institute, University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Zarzeczny","sequence":"additional","affiliation":[{"name":"Johnson Shoyama Graduate School of Public Policy, University of Regina, Regina, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Caulfield","sequence":"additional","affiliation":[{"name":"Faculty of Law, Health Law Institute, University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"key":"2025121409025725000_8.2.e019414.1","unstructured":"International Society for Stem Cell Research. ISSCR 2017 Highlights New Discoveries in Stem Cell Research & Progress Toward Clinical Therapies.25 April 2017 http:\/\/www.isscr.org\/home\/about-us\/news-press-releases\/2016\/2017\/04\/25\/isscr-2017-highlights-new-discoveries-in-stem-cell-research-progress-toward-clinical-therapies (accessed 14 Jul 2017)."},{"key":"2025121409025725000_8.2.e019414.2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40610-016-0041-7","article-title":"Human pluripotent stem cells: advances in chondrogenic differentiation and articular cartilage regeneration","volume":"2","author":"Guzzo","year":"2016","journal-title":"Curr Mol Biol Rep"},{"key":"2025121409025725000_8.2.e019414.3","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf4620"},{"key":"2025121409025725000_8.2.e019414.4","unstructured":"International Society for Stem Cell Research. Patient handbook on stem cell therapies. 2008 http:\/\/www.closerlookatstemcells.org\/docs\/default-source\/patient-resources\/patient-handbook-english.pdf?sfvrsn=4 (accessed 14 Jul 2017)."},{"key":"2025121409025725000_8.2.e019414.5","unstructured":"A Closer Look at Stem Cells. Nine things to know about stem cell treatments (ISSCR). 2015 http:\/\/www.closerlookatstemcells.org\/stem-cells-and-medicine\/nine-things-to-know-about-stem-cell-treatments (accessed 14 Jul 2017)."},{"key":"2025121409025725000_8.2.e019414.6","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMe1701379","article-title":"Polar Extremes in the Clinical Use of Stem Cells","volume":"376","author":"Daley","year":"2017","journal-title":"N Engl J Med"},{"key":"2025121409025725000_8.2.e019414.7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jcyt.2015.11.001","article-title":"Part 5: Unproven cell therapies and the commercialization of cell-based products","volume":"18","author":"Deans","year":"2016","journal-title":"Cytotherapy"},{"key":"2025121409025725000_8.2.e019414.8","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1513\/AnnalsATS.201604-277ED","article-title":"The global emergence of unregulated stem cell treatments for respiratory diseases. Professional societies need to act","volume":"13","author":"Ikonomou","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2025121409025725000_8.2.e019414.9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.stem.2016.07.015","article-title":"Global distribution of businesses marketing stem cell-based interventions","volume":"19","author":"Berger","year":"2016","journal-title":"Cell Stem Cell"},{"key":"2025121409025725000_8.2.e019414.10","unstructured":"U.S. Food & Drug Administration. Vaccines, blood & biologics; cellular & gene therapy products; approved products; marketed products. January 17 2017 https:\/\/www.fda.gov\/BiologicsBloodVaccines\/CellularGeneTherapyProducts\/ApprovedProducts\/default.htm (accessed 14 Jul 2017)."},{"key":"2025121409025725000_8.2.e019414.11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2217\/rme.13.15","article-title":"Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better?","volume":"8","author":"Ogbogu","year":"2013","journal-title":"Regen Med"},{"key":"2025121409025725000_8.2.e019414.12","doi-asserted-by":"publisher","DOI":"10.1002\/stem.132"},{"key":"2025121409025725000_8.2.e019414.13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.stem.2016.06.007","article-title":"Selling stem cells in the USA: assessing the direct-to-consumer industry","volume":"19","author":"Turner","year":"2016","journal-title":"Cell Stem Cell"},{"key":"2025121409025725000_8.2.e019414.14","unstructured":"The Cystic Fibrosis Foundation. Stem cell therapies and research for cystic fibrosis. March 9 2015 https:\/\/www.cff.org\/News\/News-Archive\/2015\/Stem-Cell-Therapies-and-Research-for-Cystic-Fibrosis\/ (accessed 22 Aug 2017)."},{"key":"2025121409025725000_8.2.e019414.15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2217\/rme.15.80","article-title":"New regulation for clinical stem cell research in China: expected impact and challenges for implementation","volume":"11","author":"Rosemann","year":"2016","journal-title":"Regen Med"},{"key":"2025121409025725000_8.2.e019414.16","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag0426"},{"key":"2025121409025725000_8.2.e019414.17","unstructured":"Health on the Net Foundation. The commitment to reliable health and medical information on the internet.. http:\/\/www.hon.ch\/HONcode\/Patients\/Visitor\/visitor.html (accessed 16 Nov 2017)."},{"key":"2025121409025725000_8.2.e019414.18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/8243095","article-title":"Quality of health information on the internet for urolithiasis on the Google search engine","volume":"2016","author":"Chang","year":"2016","journal-title":"Adv Urol"},{"key":"2025121409025725000_8.2.e019414.19","first-page":"311","article-title":"Combating unlicensed stem cell interventions through truthful advertising law: a survey of regulatory trends","volume":"9","author":"Ogbogu","year":"2016","journal-title":"MJLH"},{"key":"2025121409025725000_8.2.e019414.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2014.06.016"},{"key":"2025121409025725000_8.2.e019414.21","unstructured":"California Naturopathic Doctors Association. Naturopathic doctors are primary care doctors. CNDA. http:\/\/www.calnd.org\/files\/CNDA%20NDs%20are%20Primary%20Care%20Doctors%20FINAL%202-18-13.pdf (accessed 15 Nov 2017)."},{"key":"2025121409025725000_8.2.e019414.22","unstructured":"The American Association of Naturopathic Physicians. What is a Naturopathic Doctor? AANP. 2017 http:\/\/www.naturopathic.org\/content.asp?contentid=60 (accessed 15 Nov 2017)."},{"key":"2025121409025725000_8.2.e019414.23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1710-1492-7-14","article-title":"Supported by science?: what Canadian naturopaths advertise to the public","volume":"7","author":"Caulfield","year":"2011","journal-title":"Allergy Asthma Clin Immunol"},{"key":"2025121409025725000_8.2.e019414.24","unstructured":"Caulfield T . Blinded by science: modern-day hucksters are cashing in on vulnerable patients. The walrus, sept. 2011;12 https:\/\/thewalrus.ca\/blinded-by-science\/"},{"key":"2025121409025725000_8.2.e019414.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.2007.04569.x"},{"key":"2025121409025725000_8.2.e019414.26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med"},{"key":"2025121409025725000_8.2.e019414.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2008.11.001"},{"key":"2025121409025725000_8.2.e019414.28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/rme.15.64","article-title":"The current status of clinics providing private practice cell therapy in Japan","volume":"11","author":"Fujita","year":"2016","journal-title":"Regen Med"},{"key":"2025121409025725000_8.2.e019414.29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-8-26"},{"key":"2025121409025725000_8.2.e019414.30","unstructured":"Business Wire. Research and Markets: Global Cosmetics Market 2015-2020: Market was $460 Billion in 2014 and is Estimated to Reach $675 Billion by 2020. July 27 2015. https:\/\/www.businesswire.com\/news\/home\/20150727005524\/en\/Research-Markets-Global-Cosmetics-Market-2015-2020-Market"},{"key":"2025121409025725000_8.2.e019414.31","unstructured":"Weeks C . Are we being served by the regulation of naturopaths? Not if patients are still being misled.\u00a0The globe and mail. 2016. https:\/\/www.theglobeandmail.com\/life\/health-and-fitness\/health\/canadian-naturopaths-need-to-follow-the-rules-if-they-want-regulation\/article29785140\/ (accessed 14 Jul 2017)."},{"key":"2025121409025725000_8.2.e019414.32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/1467-9930.00132","article-title":"Opening the door to complementary and alternative medicine: self-regulation in Ontario","volume":"24","author":"Gilmour","year":"2002","journal-title":"Law and Policy"},{"key":"2025121409025725000_8.2.e019414.33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1467-9566.2004.00387.x","article-title":"Moving forward? Complementary and alternative practitioners seeking self-regulation","volume":"26","author":"Welsh","year":"2004","journal-title":"Sociol Health Illn"},{"key":"2025121409025725000_8.2.e019414.34","unstructured":"Medical Board of California (MBC). In the Matter of the Accusation against Darryl Matthew See, M.D. Division of Medical Quality, Medical Board of California, Department of Consumer Affairs, State of California. Case No. 04-2004-161179.. 2007. http:\/\/www.casewatch.org\/board\/med\/see\/surrender.pdf"},{"key":"2025121409025725000_8.2.e019414.35","unstructured":"SMC (Singapore Medical Council). Disciplinary inquiry for Dr Wong Yoke Meng. 2010. http:\/\/www.healthprofessionals.gov.sg\/content\/dam\/hprof\/smc\/docs\/press_releases\/14.Press%20Release_Dr%20Wong%20Yoke%20Meng_3Nov10.pdf"},{"key":"2025121409025725000_8.2.e019414.36","unstructured":"SMC (Singapore Medical Council). Press release: disciplinary inquiry for Dr Wong Yoke Meng. 2010. http:\/\/www.healthprofessionals.gov.sg\/content\/dam\/hprof\/smc\/docs\/press_releases\/15.Press%20Release_Dr%20Wong%20Yoke%20Meng4_9Nov10.pdf"},{"key":"2025121409025725000_8.2.e019414.37","unstructured":"Competition Act, R.S.C. 1985 , c. C-34, s. 74.01(1)(a)."},{"key":"2025121409025725000_8.2.e019414.38","unstructured":"Federal Trade Commission. (2000) Advertising and Marketing on the Internet: Rules of the Road. https:\/\/www.ftc.gov\/tips-advice\/business-center\/guidance\/advertising-marketing-internet-rules-road (accessed 14 Jul 2017)."},{"key":"2025121409025725000_8.2.e019414.39","unstructured":"Federal Trade Commission.. (2016) Federal Trade Commission Act Sect 5: Unfair or Deceptive Acts or Practices.. (https:\/\/www.federalreserve.gov\/boarddocs\/supmanual\/cch\/ftca.pdf)."},{"key":"2025121409025725000_8.2.e019414.40","unstructured":"Competition Act, RSC 1985, c C-34."},{"key":"2025121409025725000_8.2.e019414.41","unstructured":"Competition Bureau. \u201cFalse and misleading representations and deceptive marketing practices under the competition act\u201d. 3 Nov 2011. http:\/\/www.competitionbureau.gc.ca\/eic\/site\/cb-bc.nsf\/eng\/03133.html"},{"key":"2025121409025725000_8.2.e019414.42","doi-asserted-by":"crossref","unstructured":"Barnes PM , Bloom B , Nahin R . CDC National Health Statistics Report #12. Complementary and alternative medicine use among adults and children. United States, 2008. Dec 10 2008.","DOI":"10.1037\/e623942009-001"},{"key":"2025121409025725000_8.2.e019414.43","unstructured":"Competition Bureau. False or misleading representations and deceptive marketing practices. http:\/\/www.competitionbureau.gc.ca\/eic\/site\/cb-bc.nsf\/eng\/03133.html"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-019414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:03:06Z","timestamp":1765731786000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-019414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,28]]},"published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1136\/bmjopen-2017-019414"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-019414","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732783568.793543674","asserted-by":"object"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}